drugset / Trial / NCT01914042

Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica

NCT01914042

Phase 2 Unknown 150 enrolled Rambam Health Care Campus
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical, psychophysical, behavioral or genetic factor will predict the response to opioid treatment in patients with chronic neuropathic pain.

Timeline

Start
2013-07
Primary completion
2019-07
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milnacipran Other / unclassified 75 mg Oral
Subject Morphine Other / unclassified 60 mg Oral

Indications